Artritis urica (giht) je klinički sindrom čije su glavne karakteristike recidivirajuća upala jednog ili više zglobova zbog hipersaturacije mokraćne kiseline i odlaganja kristala urata u zglobove i okozglobne strukture, stvaranje tofa, deformacije zglobova zbog uratne artropatije i nastanak uratne nefropatije. U zavisnosti od faze bolesti ispoljava se bolovima u zahvaćenim zglobovima, recidivnim artritisom najčešće u bazalnom zglobu palca ili ređe u drugim zglobovima stopala praćen deformacijama. U radu je obrađeno 40 ispitanika i prezentovani su rezultati kliničkih manifestacija bolesti, laboratorijski, radiološki nalaz i prisustvo konkomitantnih bolesti.
Ida K, Sersu M, Fujieda K, Kawano S, Tabei F, Iwasaki Y. Pathologic significance of left ventricular hypertrophy in dilated cardiomyopathy. Clin Cardiol. 1996;704–8.
2.
Eggebeen A, Choi H. Purine-rich foods, dairy and protein intake, and the risk of gout in men. The New England Journal of Medicine. 2007;(11):1093.
3.
Dehghan A, Köttgen, Yang Q. Association of three genetic loci with uric acid concentration and risk of gout: a genomewide association study. Lancet. 2008;1953–61.
4.
Lin K, Lin H, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol. 2000;1501–5.
5.
Kramer H, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis. 2002;37–42.
6.
Mcgill N. Gout and other crystal-associated arthropathies. Baillieres Best Pract Res Clin Rheumatol. 2000;445–60.
7.
Becker M. Arthritis and Allied Conditions: A textbook of Rheumatology edition 15. 2005;2303–39.
8.
Lin K, Lin H, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol. 2000;1501–5.
9.
Eggebeen A. Gout: an update. Am Fam Physician. 2007;801–8.
10.
Williams P. Effects of diet, physical activity and performance, and body weight on incident gout in ostensible healthy, vigorously active men. Am J Clin Nutr. 2008;1480–7.
11.
Choi H, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008;309–12.
12.
Underwood M. Acute gout. Clin Evid. 2003;1238–46.
13.
Ali S, Lally E, Lally E. Treatment failure gout. Medicine and health, Rhode Island. (11):369–71.
14.
Zhang W, Doherty M, Bardin T. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;1301–11.
15.
Uhlig T. Urinsyregikt og hyperurikemi -skal begge deler behandles? Tidsskr Nor Laegeforen. 2003;2878–80.
16.
Khanna D, Fitzgerald J, Khanna P. American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and Antiinflammatory Prophylaxis of Acute Gouty Arthritis. Arthr Care Res. 2012;1447–61.
17.
Underwood M. Diagnosis and management of gout. BMJ. 2006;1315–9.
18.
Zhang W, Doherty M, Pascual E. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2006;1301–11.
19.
Choi H, Atkinson K, Karlson E, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005;742–8.
20.
Fang J, Alderman M. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971 -1992. National Health and Nutrition Examination Survey. JAMA. 2000;2404–10.
21.
Janssens H, Janssen M, Van De Lisdonk E. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;1854–60.
22.
Man C, Cheung I, Cameron P, Rainer T. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med. 2007;670–7.
23.
Harris M, Bryant L, Danaher P, Alloway J. Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis. J Rheumatol. 2000;2873–6.
24.
Feig D, Soletsky B, Johnson R. Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial. JAMA. 2008;924–32.
25.
Reinders M, Haagsma C, Jansen T. A randomised controlled trial on the efficacy and tolerability with dose-escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout. Ann Rheum Dis. 2008;
26.
Gelber A, Klag M, Mead L. Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med. 1997;1436–40.
27.
Culleton B. Uric acid and cardiovascular disease: a renal-cardiac relationship? Curr Opin Nephrol Hypertens. 2001;371–5.
28.
Johnson R, Rideout B. Uric acid and diet -insights into the epidemic of cardiovascular disease. N Engl J Med. 2004;1071–2.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
